Home Immunotherapy Researchers Investigate Coated Prussian Blue Nanoparticles for Cancer Immunotherapies

Researchers Investigate Coated Prussian Blue Nanoparticles for Cancer Immunotherapies

198
0
Immunotherapy

Researchers from the George Washington University (GW) Cancer Center has engineered a  

k News) A team from the George Washington University (GW) Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer. The goal of this nanoimmunotherapy combination is to increase the potency of immune checkpoint inhibitors, a class of immunotherapy that elicits dramatic benefits in only a modest subset of cancer patients, to a significantly larger proportion of patients
Rohan Fernandes, PhD, assistant professor of medicine at the GW School of Medicine and Health Sciences, received more than $1.6 million from the National Institutes of Health for the study. The grant is a R37 award, which is a MERIT — Method to Extend Research in Time — Award for early stage investigators to give them the flexibility and opportunity for creativity and innovation, as well as, additional time to successfully launch their careers.
The researchers will work with Prussian blue nanoparticles (PBNPs) coated with immunological signals, used in combination with checkpoint inhibitors. Rohan Fernandes, PhD

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.